title: Neuro-oncology: a step towards clinical blood biomarkers of glioblastoma.
abstract: Glioblastoma is the most common primary brain tumour in adults, but— unlike many other cancers—no blood-based biomarkers are available for differential diagnosis, estimation of prognosis or monitoring of treatment response in glioblastoma. New research has detected three proteins with potential clinical value in the blood of patients with glioblastoma.
authors.affiliation: Department of Medicine I, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
authors.forename: Matthias
authors.initials: M
authors.lastname: Preusser
mesh_terms: D054392:Adipokines / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D001932:Brain Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D000071451:Chitinase-3-Like Protein 1; D005904:Glial Fibrillary Acidic Protein / Q000097:blood; D005909:Glioblastoma / Q000097:blood* / Q000175:diagnosis; D006801:Humans; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000097:blood; D037102:Lectins / Q000097:blood
chemical_list: D054392:Adipokines; D014408:Biomarkers, Tumor; C084533:CHI3L1 protein, human; D000071451:Chitinase-3-Like Protein 1; D005904:Glial Fibrillary Acidic Protein; C577903:IGFBP2 protein, human; D018971:Insulin-Like Growth Factor Binding Protein 2; D037102:Lectins